β³ Fetching live dividend data...
Home βΊ Calculator βΊ GEHC Dividend Calculator 2026
GE HealthCare Technologies Inc. Β· NASDAQ
Price: $63.88 Β· Annual div: $0.14/share Β· Frequency: quarterly Β· Payout ratio: 50% Β· Ex-div: TBD
GEHC is not a dividend-focused stock
GEHC pays a very low or no dividend (Yield: 0.22%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in GEHC β $60.9K in 10 years Β· $1.84/month
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, and X-ray systems, as well as women's health products. The Ultrasound segment provides screening, diagnosis, treatment, and monitoring of certain diseases through radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment involved in the provision of medical devices, consumable products, services, and digital solutions through patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal infant care products. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals, administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents, or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes that are injected into a patient prior to a diagnostic imaging scan. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. Β· Privacy Policy
Ready to invest? Open GEHC position with:
Real after-tax yield depends on where you live and how you hold GEHC.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| πΊπΈ Roth IRA / 401k | 0% | 0.22% | -2.58% | $22 / yr |
| πΊπΈ US Taxable (15%) β | 15% | 0.19% | -2.61% | $19 / yr |
| πΊπΈ US Taxable (20%) | 20% | 0.18% | -2.62% | $18 / yr |
| π¬π§ UK ISA | 0% | 0.22% | -2.58% | $22 / yr |
| π¬π§ UK Taxable | 8.75% | 0.20% | -2.60% | $20 / yr |
| π¨π¦ TFSA | 0% | 0.22% | -2.58% | $22 / yr |
| π¨π¦ CA Taxable | 25% | 0.17% | -2.63% | $17 / yr |
| π¦πΊ Super (pension) | 15% | 0.19% | -2.61% | $19 / yr |
| π¦πΊ AU Taxable | 30% | 0.15% | -2.65% | $15 / yr |
| π©πͺ DE Taxable | 26.375% | 0.16% | -2.64% | $16 / yr |
| π«π· FR Taxable | 30% | 0.15% | -2.65% | $15 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $0.14/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
GEHC pays quarterly β 4 times per year. Next ex-div: TBD.
How GEHC compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for GEHC sourced from FMP /financial-growth endpoint β real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Buy | 2026-05-22 | 10,000 | $64.18 | $641.8K | ||
| A-Award | 2026-05-15 | 16,458 | β | β | ||
| F-InKind | 2026-05-15 | 5,535 | $62.67 | $346.9K | ||
| Buy | 2026-05-12 | 1,618 | $62.03 | $100.4K | ||
| Buy | 2026-05-08 | 1,000 | $63.01 | $63.0K | ||
| A-Award | 2026-05-07 | 3,586 | β | β | ||
| A-Award | 2026-05-07 | 4,157 | β | β | ||
| A-Award | 2026-05-07 | 3,586 | β | β | ||
| A-Award | 2026-05-07 | 2,689 | β | β | ||
| A-Award | 2026-05-07 | 3,586 | β | β |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores β lower dividend cut risk. Data via FMP financial statements.
Insiders are net buyers β historically a positive signal for dividend sustainability. Last purchase: 2026-05-22
Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the GEHC dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β
Real users. No sign-up required to leave a review.
βFinally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.β
βI've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly β $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.β
βReally solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.β
βAs someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.β
βThe Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.β
Reviews reflect users' personal experiences. Not financial advice.
Leave a review β